Cytokine dysregulation as a mechanism of graft versus host disease

This publication has 27 references indexed in Scilit:

• Cytokine gene expression in mice undergoing chronic graft-versus-host disease
  Molecular Immunology, 1993
• Differential cytokine expression in acute and chronic murine graft‐versus‐host‐disease
  European Journal of Immunology, 1993
• Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation
  The Lancet, 1993
• Effects of in vivo administration of interferon (IFN)-γ, anti-IFN-γ, or anti-interleukin-4 monoclonal antibodies in chronic autoimmune graft-versus-host disease
  Clinical Immunology and Immunopathology, 1992
• SERUM LEVELS AND RECEPTOR EXPRESSION OF TUMOR NECROSIS FACTOR-α FOLLOWING HUMAN ALLOGENEIC AND AUTOLOGOUS BONE MARROW TRANSPLANTATION
  Transplantation, 1992
• Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease.
  The Journal of Experimental Medicine, 1992
• Enhancement of Growth of Virulent Strains of Escherichia coli by Interleukin-1
  Science, 1991
• ENDOGENOUS IFN-GAMMA DURING HUMAN BONE MARROW TRANSPLANTATION
  Transplantation, 1990
• In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment.
  The Journal of Experimental Medicine, 1990
• Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.
  The Journal of Experimental Medicine, 1987